The start of the activities of the eighth training course for nephrology with the theme of kidney transplant diseases for African at Urology & Nephrology Center - Mansoura University in cooperation with the Egyptian Agency for Partnership for Development from 13/3/2022 to 17/3/2022 in the presence of Prof. Dr. Ashraf Tarek, Vice President The university for postgraduate studies and scientific research, Prof. Tamer Abu El-Saad, Vice Dean for Graduate Studies and Research Affairs, Prof. Bassem Salah Wadie, Director of Urology & Nephrology Center, and Prof. Ayman Refaie, Deputy Director of the Center, Head of Dialysis Unit and Course director.

DAKO Autostainer link 48 Immunohistochemistry staining system aims at accurately deliver the precise diagnosis to our patients on time. Our lab adapts to meet changing demands, so we are now able to adopt the latest IHC developments rapidly and easily.The high quality instrument precision and stability contribute to reliable, high quality results, slide after slide to enable correct diagnosis on tissue samples. It meets our present and future diagnostic needs, manage complex patient cases and maintain optimal productivity and quality.

Opening Ceremony of the The 16th International Training Course on Invasive Bladder Cancer and Urinary Diversion Techniques Urology & Nephrology Center, Mansoura University 23rd -27th December, 2018 Opening Ceremony of the 16th International Training Course on Invasive Bladder Cancer and Urinary Diversion Techniques Urology & Nephrology Center, Mansoura University Prof. Said Abdul Hadi; Dean of the Faculty of Medicine, Prof. Ahmed Shoma; Chief of Department of Urology , Prof. Bassem S. Wadie; Urology & Nephrology Center Director, Prof. Hassan Abol-Enein; Course

MRI/US fusion targeted biopsy is a technique involves using different software platforms to integrate the MRI data to the ultrasound for a more accurate biopsy. It has the advantages of reducing the detection of clinically insignificant disease, maximizing the detection of clinically significant cancer, along with better assessment of disease size, grade, and location.

On Monday 17th December, 2018,  Prof. Philip Van Kerrebroeck, Professor of Urology at the University of Maastricht, and he works as a urologist at the Maastricht University Medical Centre, Netherlands.